Quarterly report pursuant to Section 13 or 15(d)

NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.24.1.1.u2
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

    2024     2023  
    For the three months ended March 31,  
    2024     2023  
             
Shares of common stock issuable upon exercise of stock options     179,001       234,697  
Shares of common stock underlying restricted stock     2,542,619       929,946  
Shares of common stock issuable upon exercise of warrants     9,903,142       9,397,879  
Total     12,624,762       10,562,522